Feed BLHWF
BL

BELIMO Holding AG BLHWF · OTC

$990.13 +7.30% (+$67.33)

Summary

71 / 100 · Bulios Score

What speaks for it

  • Out of every 100 CHF of revenue, 17 CHF is left as net profit.
  • It earns 19 CHF a year on every 100 CHF of invested capital.
  • Earnings per share grew by 14% a year over the last 3 years.
  • Analysts expect revenue to grow by 17% this fiscal year.

What to watch

  • The share price is above the Bulios Fair Price.
  • It passes only 3 of the 9 points of the Piotroski financial health test.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Current price $990.13
P/E today 48.8 2.9% higher
5-year average P/E 47.4
P/E today 48.8
Industrial - Machinery industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 48.8 CHF for 1 CHF of yearly profit. Over the last five years it was 47.4 CHF on average.

Valuation in detail

Is it growing?

Yes, fast

Revenue (CHF)

Diluted EPS (CHF)

  • Analyst estimate

Revenue grew by 11% a year over 5 years. Over the last 3 years it grew by 9.8% a year. For the next fiscal year analysts expect revenue to grow by 17%. Earnings per share grew by 14% a year over the last 3 years.

Growth in detail

Does it make money?

Reasonably

Where 100 CHF of revenue goes

Net profit, industry median (Industrial - Machinery) 7.0 CHF

Out of every 100 CHF of revenue, 17 CHF is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

Repaying all its debt would take 1.5 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

Small, at risk
Yield
1.27%
Paid out of profit
62%
Raised in a row
1 year

You receive $12.60 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

Mildly positive

No analyst has published a price target.

50% of the analysts recommend buying.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy